GeoVax Labs, Inc.
GOVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000832489
No open-market purchases or sales by GeoVax Labs, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $625.5K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in GeoVax Labs, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q3 2025
- Shares held
- 2.75M
- +802.7K (+41.3%) vs. Q3 2025
- Total value
- $468.7K
- −$450.6K (−49.0%) vs. Q3 2025
- New holders
- 6
- 3 more added
- Sold out
- 5
- 4 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $625.5K |
| Q1 2026 | 16 | $459.6K |
| Q4 2025 | 22 | $468.7K |
| Q3 2025 | 21 | $919.3K |
| Q2 2025 | 21 | $478.3K |
| Q1 2025 | 18 | $1.24M |
| Q4 2024 | 19 | $715.6K |
| Q3 2024 | 17 | $1.08M |
| Q2 2024 | 12 | $619.1K |
| Q1 2024 | 11 | $481.2K |
| Q4 2023 | 16 | $1.13M |
| Q3 2023 | 14 | $797.6K |
| Q2 2023 | 16 | $886.0K |
| Q1 2023 | 17 | $1.07M |
| Q4 2022 | 20 | $1.35M |
| Q3 2022 | 23 | $3.39M |
| Q2 2022 | 19 | $2.02M |
| Q1 2022 | 16 | $1.09M |
| Q4 2021 | 15 | $1.68M |
| Q3 2021 | 13 | $1.98M |
| Q2 2021 | 10 | $1.99M |
| Q1 2021 | 10 | $1.22M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding GeoVax Labs, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 120 | $21 | 0.00% | −25,000−99.5% | Reduced |
| Wells Fargo & Company | 250 | $43 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 264 | $45 | 0.00% | −444−62.7% | Reduced |
| Farther Finance Advisors, LLC | 494 | $84 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 4,124 | $705 | 0.00% | +10+0.2% | Added |
| Advisor Group Holdings, Inc. | 5,000 | $855 | 0.00% | −400−7.4% | Reduced |
| State Street Corp | 16,828 | $2.88K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 27,565 | $4.71K | 0.00% | 00.0% | Unchanged |
| Fiduciary Alliance LLC | 35,000 | $5.99K | 0.00% | +35,000 | New |
| XTX Topco Ltd | 60,978 | $10.4K | 0.00% | +60,978 | New |
| Northern Trust Corp | 64,711 | $11.1K | 0.00% | +53,036+454.3% | Added |
| UBS Group AG | 89,501 | $15.3K | 0.00% | +31,073+53.2% | Added |
| HRT Financial LP | 185,223 | $31.0K | 0.00% | +185,223 | New |
| Geode Capital Management, LLC | 207,074 | $35.4K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 244,163 | $41.8K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 581,584 | $99.5K | 0.00% | +581,584 | New |
| Renaissance Technologies LLC | 606,528 | $103.7K | 0.00% | +606,528 | New |
| Citadel Advisors LLC | 615,373 | $105.2K | 0.00% | +615,373 | New |
| Moneta Group Investment Advisors LLC | 800 | – | – | −19,200−96.0% | Reduced |
| Quaker Wealth Management, LLC | 1 | – | – | 00.0% | Unchanged |
| Sabby Management, LLC | 0 | $0 | 0.00% | −661,376−100.0% | Sold out |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −533,897−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −16,124−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −9,708−100.0% | Sold out |